In silico Molecular Docking and ADME Studies of 1 3,4-Thiadiazole Derivatives in Relation to in vitro PON1 Activity

SEVER, BELGİN; KÜÇÜKOĞLU, KAAN; NADAROĞLU, Hayrunnisa; ALTINTOP, MEHLİKA

doi:10.2174/1573409914666180518085908

In silico Molecular Docking and ADME Studies of 1 3,4-Thiadiazole Derivatives in Relation to in vitro PON1 Activity

SEVER B., KÜÇÜKOĞLU K., NADAROĞLU H., ALTINTOP M. D.

CURRENT COMPUTER-AIDED DRUG DESIGN, vol.15, no.2, pp.136-144, 2019 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 15 Issue: 2
Publication Date: 2019
Doi Number: 10.2174/1573409914666180518085908
Journal Name: CURRENT COMPUTER-AIDED DRUG DESIGN
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.136-144
Keywords: Paraoxonase 1, thiadiazole, molecular docking, ADME, antioxidant activity, PON1 activators, HUMAN SERUM PARAOXONASE, PURIFICATION, BINDING, 1,3,4-THIADIAZOLES, INHIBITION, SOLUBILITY, PROTEINS, DESIGN
Anadolu University Affiliated: Yes

Abstract

Background: Paraoxonase 1 (PON1) is a paraoxonase, arylesterase and lactonase associated with protection of lipoproteins and cell membranes against oxidative modification.